DNA microarrays to define and search for genes associated with obesity

Biotechnology Journal

Volumn 5, Issue 1, 2010, Pages 99-112

  Kim, Yunjung ^a   Park, Taesun ^a  

^a Yonsei University   (South Korea)

Author keywords

Adipose tissue; Liver; Microarray; Obesity

Indexed keywords

ADHESION MOLECULES; ADIPOCYTE DIFFERENTIATION; ADIPOSE TISSUE; ANIMAL MODEL; DNA MICRO-ARRAY; FATTY ACID BIOSYNTHESIS; FATTY ACID OXIDATION; FREE FATTY ACID; GENE EXPRESSION PROFILES; HEPATIC TISSUE; IMMUNE RESPONSE; LIPID METABOLISMS; METABOLIC DISEASE; NON-ALCOHOLIC FATTY LIVER; OVER-EXPRESSION; PATHOGENIC MECHANISMS; RESPIRATORY ACTIVITY; STRESS RESPONSE; THERAPEUTIC TARGETS; WEALTH OF INFORMATION; WHITE ADIPOSE TISSUES;

ACIDS; BIOACTIVITY; BIOASSAY; BIOCHEMISTRY; BIOCHIPS; FATTY ACIDS; HISTOLOGY; LIVER; MAMMALS; METABOLISM; MOLECULAR WEIGHT; NUTRITION; TISSUE;

GENE EXPRESSION;

CELL ADHESION MOLECULE;

ADIPOSE TISSUE; CELL DIFFERENTIATION; DNA MICROARRAY; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INSULIN SENSITIVITY; LIPID METABOLISM; LIVER; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; GENE EXPRESSION PROFILING; GENETIC TESTING; HUMANS; LIVER; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

ANIMALIA; RODENTIA;

EID: 75649148583     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.200900228     Document Type: Review

References (84)

1. Schena, M., Shalon, D., Davis, R.W., Brown, P. O., Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270, 467-470.
2. Cagney, G., Park, S., Chung, C., Tong, B. et al., Human tissue profiling with multidimensional protein identification technology. J. Proteome Res. 2005, 4, 1757-1767.
3. Aitman, T. J., Glazier, A. M., Wallace, C. A., Cooper, L.D. et al., Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet. 1999, 21, 76-83.
4. Jiang, Y., Harlocker, S. L., Molesh, D. A., Dillon, D. C. et al., Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarrays. Oncogene 2002, 21, 2270-2282.
5. Moreno-Aliaga, M. J., Marti, A., Garcia-Foncillas, J., Alfredo Martinez, J., DNA hybridization arrays: A powerful technology for nutritional and obesity research. Br. J. Nutr. 2001, 86, 119-122.
6. Brown, P. O., Hartwell, L., Genomics and human disease - Variations on variation. Nat. Genet. 1998, 18, 91-93.
7. DeRisi, J., Penland, L., Brown, P. O., Bittner, M. L. et al., Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 1996, 14, 457-460.
8. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation.World Health Organ.Tech. Rep. Ser. 2000, 894, i-xii, 1-253.
9. Soukas, A., Cohen, P., Socci, N. D., Friedman, J. M., Leptinspecific patterns of gene expression in white adipose tissue. Genes Dev. 2000, 14, 963-980.
10. Nadler, S. T., Stoehr, J. P., Schueler, K. L., Tanimoto, G. et al., The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc. Natl. Acad. Sci. USA 2000, 97, 11371-11376.
11. Moraes, R. C., Blondet, A., Birkenkamp-Demtroeder, K., Tirard, J. et al., Study of the alteration of gene expression in adipose tissue of diet-induced obese mice by microarray and reverse transcription-polymerase chain reaction analyses. Endocrinology 2003, 144, 4773-4782.
12. Lopez, I. P., Marti, A., Milagro, F. I., Zulet Md Mde, L. et al., DNA microarray analysis of genes differentially expressed in diet-induced (cafeteria) obese rats. Obes. Res. 2003, 11, 188-194.
13. Middleton, F. A., Ramos, E. J. B., Xu, Y., Diab, H. et al., Application of genomic technologies: DNA microarrays and metabolic profiling of obesity in the hypothalamus and in subcutaneous fat. Nutrition 2004, 20, 14-25.
14. Lopez, I.P., Milagro, F. I., Marti, A., Moreno-Aliaga, M.J. et al., High-fat feeding period affects gene expression in rat white adipose tissue. Mol. Cell. Biochem. 2005, 275, 109-115.
15. Van Schothorst, E. M., Franssen-van Hal, N., Schaap, M. M., Pennings, J. et al., Adipose gene expression patterns of weight gain suggest counteracting steroid hormone synthesis. Obes. Res. 2005, 13, 1031-1041.
16. Campion, J., Milagro, F. I., Fernandez, D., Martinez, J. A., Diferential gene expression and adiposity reduction induced by ascorbic acid supplementation in a cafeteria model of obesity. J. Physiol. Biochem. 2006, 62, 71-80.
17. Kim, Y. J., Park, T., Genes are differentially expressed in the epididymal fat of rats rendered obese by a high-fat diet. Nutr. Res. 2008, 28, 414-422.
18. Miller, R. S., Becker, K.G., Prabhu, V., Cooke, D.W., Adipocyte gene expression is altered in formerly obese mice and as a function of diet composition. J. Nutr. 2008, 138, 1033-1038.
19. Ferrante, A.W., Jr., Thearle, M., Liao, T., Leibel, R. L., Effects of leptin deficiency and short-term repletion on hepatic gene expression in genetically obese mice. Diabetes 2001, 50, 2268-2278.
20. Liang, C.P., Tall, A. R., Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver. J. Biol. Chem. 2001, 276, 49066-49076.
21. Deng, X., Elam, M. B., Wilcox, H. G., Cagen, L. M. et al., Dietary olive oil and menhaden oil mitigate induction of lipogenesis in hyperinsulinemic corpulent JCR:LA-cp rats: Microarray analysis of lipid-related gene expression. Endocrinology 2004, 145, 5847-5861.
22. Kim, S., Sohn, I., Ahn, J. I., Lee, K. H., Lee, Y. S., Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene 2004, 340, 99-109.
23. Inoue, M., Ohtake, T., Motomura, W., Takahashi, N. et al., Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice. Biochem. Biophys. Res.Commun.2005, 336, 215-222.
24. Patsouris, D., Reddy, J. K., Muller, M., Kersten, S., Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression. Endocrinology 2006, 147, 1508-1516.
25. Yang, R. L., Li, W., Shi, Y. H., Le, G.W., Lipoic acid prevents high-fat diet-induced dyslipidemia and oxidative stress: A microarray analysis. Nutrition 2008, 24, 582-588.
26. Xu, R.Y., Wan, Y. P., Tang, Q.Y., Wu, J., Cai, W., The effects of high fat on central appetite genes in Wistar rats: A microarray analysis. Clin. Chim. Acta 2008, 397, 96-100.
27. Sreekumar, R., Unnikrishnan, J., Fu, A., Nygren, J. et al., Impact of high-fat diet and antioxidant supplement on mitochondrial functions and gene transcripts in rat muscle. Am. J. Physiol. Endocrinol. Metab. 2002, 282, E1055-1061.
28. de Wit, N. J., Bosch-Vermeulen, H., de Groot, P. J., Hooiveld, G. J. et al., The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice. BMC Med. Genomics 2008, 1, 14.
29. Naito, Y., Uchiyama, K., Mizushima, K., Kuroda, M. et al., Microarray profiling of gene expression patterns in glomerular cells of astaxanthin-treated diabetic mice: A nutrigenomic approach. Int. J. Mol. Med. 2006, 18, 685-695.
30. Gomez-Ambrosi, J., Catalan, V., Diez-Caballero, A., Martinez-Cruz, L. A. et al., Gene expression profile of omental adipose tissue in human obesity. FASEB J. 2004, 18, 215-217.
31. Baranova, A., Collantes, R., Gowder, S. J., Elariny, H. et al., Obesity-related differential gene expression in the visceral adipose tissue. Obes. Surg. 2005, 15, 758-765.
32. Lee, Y. H., Nair, S., Rousseau, E., Allison, D. B. et al., Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: Increased expression of inflammation-related genes. Diabetologia 2005, 48, 1776-1783.
33. Marrades, M. P., Milagro, F. I., Martinez, J. A., Moreno-Aliaga, M. J., Differential expression of aquaporin 7 in adipose tissue of lean and obese high fat consumers. Biochem. Biophys. Res. Commun. 2006, 339, 785-789.
34. Chiappini, F., Barrier, A., Saffroy, R., Domart, M. C. et al., Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray. Lab. Invest. 2006, 86, 154-165.
35. Younossi, Z. M., Gorreta, F., Ong, J. P., Schlauch, K. et al., Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Liver Int. 2005, 25, 760-771.
36. Maebuchi, M., Machidori, M., Urade, R., Ogawa, T., Moriyama, T., Low resistin levels in adipose tissues and serum in high-fat fed mice and genetically obese mice: Development of an ELISA system for quantification of resistin. Arch. Biochem. Biophys. 2003, 416, 164-170.
37. Yang, X., Schadt, E. E., Wang, S., Wang, H. et al., Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res. 2006, 16, 995-1004.
38. Uysal, K.T., Wiesbrock, S. M., Marino, M.W., Hotamisligil, G. S., Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389, 610-614.
39. Rasouli, N., Kern, P. A., Adipocytokines and the metabolic complications of obesity. J. Clin. Endocrinol. Metab. 2008, 93, S64-73.
40. Nadler, S.T., Attie, A. D., Please pass the chips: Genomic insights into obesity and diabetes. J. Nutr. 2001, 131, 2078-2081.
41. Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D. et al., Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25, 25-29.
42. Havel, P. J., Update on adipocyte hormones: Regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004, 53 Suppl 1, S143-151.
43. You, T., Nicklas, B. J., Chronic inflammation: Role of adipose tissue and modulation by weight loss. Curr. Diabetes Rev. 2006, 2, 29-37.
44. Henegar, C., Tordjman, J., Achard, V., Lacasa, D. et al., Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol. 2008, 9, R14.
45. Zhang, Y., Proenca, R., Maffei, M., Barone, M. et al., Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372, 425-432.
46. Farooqi, I. S., Keogh, J. M., Kamath, S., Jones, S. et al., Partial leptin deficiency and human adiposity. Nature 2001, 414, 34-35.
47. Strobel, A., Issad, T., Camoin, L., Ozata, M., Strosberg, A. D., A leptin missense mutation associated with hypogonadism and morbid obesity. Nat. Genet. 1998, 18, 213-215.
48. Baratta, M., Leptin - From a signal of adiposity to a hormonal mediator in peripheral tissues. Med. Sci. Monit. 2002, 8, RA282-292.
49. Minokoshi, Y., Kahn, B.B., Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle. Biochem. Soc.Trans. 2003, 31, 196-201.
50. Girard, J., Is leptin the link between obesity and insulin resistance? Diabetes Metab. 1997, 23 Suppl 3, 16-24.
51. Larsson, H., Elmstahl, S., Ahren, B., Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women. Diabetes 1996, 45, 1580-1584.
52. Baile, C.A., Della-Fera, M.A., Martin, R. J., Regulation of metabolism and body fat mass by leptin. Annu. Rev. Nutr. 2000, 20, 105-127.
53. Caro, J. F., Kolaczynski, J.W., Nyce, M. R., Ohannesian, J. P. et al., Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance. Lancet 1996, 348, 159-161.
54. Kubo, Y., Kaidzu, S., Nakajima, I., Takenouchi, K., Nakamura, F., Organization of extracellular matrix components during differentiation of adipocytes in long-term culture. In Vitro Cell Dev. Biol. Anim. 2000, 36, 38-44.
55. Han, J., Luo, T., Gu, Y., Li, G. et al., Cathepsin K regulates adipocyte differentiation: Possible involvement of type I collagen degradation. Endocr. J. 2009, 56, 55-63.
56. van Dielen, F. M., van't Veer, C., Schols, A. M., Soeters, P. B. et al., Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int. J. Obes. Relat. Metab. Disord. 2001, 25, 1759-1766.
57. Chiba, T., Han, C. Y., Vaisar, T., Shimokado, K. et al., Serum amyloid A3 does not contribute to circulating SAA levels. J. Lipid Res. 2009, 50, 1353-1362.
58. Taleb, S., Lacasa, D., Bastard, J. P., Poitou, C. et al., Cathepsin S, a novel biomarker of adiposity: Relevance to atherogenesis. FASEB J. 2005, 19, 1540-1542.
59. Yang, R. Z., Lee, M. J., Hu, H., Pollin, T. I. et al., Acute-phase serum amyloid A: An inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med. 2006, 3, e287.
60. Gao, J., Ye, H., Serrero, G., Stimulation of adipose differentiation related protein (ADRP) expression in adipocyte precursors by long-chain fatty acids. J. Cell. Physiol. 2000, 182, 297-302.
61. Magnusson, B., Asp, L., Bostrom, P., Ruiz, M. et al., Adipocyte differentiation-related protein promotes fatty acid storage in cytosolic triglycerides and inhibits secretion of very lowdensity lipoproteins. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 1566-1571.
62. Zhang, S. H., Reddick, R. L., Piedrahita, J. A., Maeda, N., Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258, 468-471.
63. Bersot, T. P., Mahley, R.W., Brown, M. S., Goldstein, J. L., Interaction of swine lipoproteins with the low density lipoprotein receptor in human fibroblasts. J. Biol. Chem. 1976, 251, 2395-2398.
64. Pullinger, C. R., Hennessy, L. K., Chatterton, J. E., Liu, W. et al., Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J. Clin. Invest. 1995, 95, 1225-1234.
65. Huang, Z. H., Luque, R. M., Kineman, R.D., Mazzone, T., Nutritional regulation of adipose tissue apolipoprotein E expression. Am. J. Physiol. Endocrinol. Metab. 2007, 293, E203-209.
66. Hayes, J. D., Flanagan, J. U., Jowsey, I. R., Glutathione transferases. Annu. Rev. Pharmacol.Toxicol. 2005, 45, 51-88.
67. Hanna, E., MacLeod, S., Vural, E., Lang, N., Genetic deletions of glutathione-S-transferase as a risk factor in squamous cell carcinoma of the larynx: A preliminary report. Am. J. Otolaryngol. 2001, 22, 121-123.
68. Widberg, C. H., Newell, F. S., Bachmann, A.W., Ramnoruth, S. N. et al., Fibroblast growth factor receptor 1 is a key regulator of early adipogenic events in human preadipocytes. Am. J. Physiol. Endocrinol. Metab. 2009, 296, E121-131.
69. Samartin, S., Chandra, R. K., Obesity, overnutrition and the immune system. Nutr. Res. 2001, 21, 243-262.
70. Nieman, D.C., Nehlsen-Cannarella, S. L., Henson, D.A., Butterworth, D. E. et al., Immune response to obesity and moderate weight loss. Int. J. Obes. Relat. Metab. Disord. 1996, 20, 353-360.
71. Charriere, G., Cousin, B., Arnaud, E., Andre, M. et al., Preadipocyte conversion to macrophage. Evidence of plasticity. J. Biol. Chem. 2003, 278, 9850-9855.
72. Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I. et al., TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 2006, 116, 3015-3025.
73. Wellen, K. E., Hotamisligil, G. S., Inflammation, stress, and diabetes. J. Clin. Invest. 2005, 115, 1111-1119.
74. Midwood, K., Sacre, S., Piccinini, A. M., Inglis, J. et al., Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat. Med. 2009, 15, 774-780.
75. Kim, J. K., Fat uses a TOLL-road to connect inflammation and diabetes. Cell Metab. 2006, 4, 417-419.
76. Jain, N., Zhang, T., Kee, W. H., Li, W., Cao, X., Protein kinase C delta associates with and phosphorylates Stat3 in an interleukin-6-dependent manner. J. Biol. Chem. 1999, 274, 24392-24400.
77. Forest, C., Tordjman, J., Glorian, M., Duplus, E. et al., Fatty acid recycling in adipocytes: A role for glyceroneogenesis and phosphoenolpyruvate carboxykinase. Biochem. Soc. Trans. 2003, 31, 1125-1129.
78. Yang, S., Zhu, H., Li, Y., Lin, H. et al., Mitochondrial adaptations to obesity-related oxidant stress. Arch. Biochem. Biophys. 2000, 378, 259-268.
79. Goldstein, J. L., Brown, M. S., Regulation of the mevalonate pathway. Nature 1990, 343, 425-430.
80. Koonen, D. P., Jacobs, R. L., Febbraio, M., Young, M. E. et al., Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes 2007, 56, 2863-2871.
81. Luiken, J. J., Arumugam, Y., Dyck, D. J., Bell, R. C. et al., Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J. Biol. Chem. 2001, 276, 40567-40573.
82. Zhou, J., Febbraio, M., Wada, T., Zhai, Y. et al., Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology 2008, 134, 556-567.
83. Ishii, T., Itoh, K., Takahashi, S., Sato, H. et al., Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 2000, 275, 16023-16029.
84. Cortez-Pinto, H., Machado, M. V., Uncoupling proteins and non-alcoholic fatty liver disease. J. Hepatol. 2009, 50, 857-860.